4//SEC Filing
Ghai Jyotsna 4
Accession 0000950170-25-002411
CIK 0001850906other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:48 PM ET
Size
7.3 KB
Accession
0000950170-25-002411
Insider Transaction Report
Form 4
Ghai Jyotsna
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2025-01-02+417→ 3,033 total - Exercise/Conversion
Restricted Stock Units
2025-01-02−417→ 4,583 total→ Common Stock (417 underlying)
Footnotes (4)
- [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Includes 100 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F4]25% of the RSUs vested on October 2, 2024; the remainder of the RSUs vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025.
Documents
Issuer
Singular Genomics Systems, Inc.
CIK 0001850906
Entity typeother
Related Parties
1- filerCIK 0001999779
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 6:48 PM ET
- Size
- 7.3 KB